Modelling and control of agitation-sedation dynamics in critically ill patients

[1]  J Geoffrey Chase,et al.  Adaptive bolus-based targeted glucose regulation of hyperglycaemia in critical care. , 2005, Medical engineering & physics.

[2]  Genís Carrasco,et al.  Instruments for monitoring intensive care unit sedation , 2000, Critical care.

[3]  G Sherman,et al.  Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. , 1999, Critical care medicine.

[4]  B. de Jonghe,et al.  Sedation algorithm in critically ill patients without acute brain injury , 2005, Critical care medicine.

[5]  J. Reves,et al.  Sedation in the intensive care unit , 2000, Critical care medicine.

[6]  J. Vender,et al.  Anxiety, delirium, and pain in the intensive care unit. , 2001, Critical care clinics.

[7]  R. Fragen.  Pharmacokinetics and pharmacodynamics of midazolam given via continuous intravenous infusion in intensive care units. , 1997, Clinical therapeutics.

[8]  D. O'Hara,et al.  Pharmacokinetics and Pharmacodynamics of Sedatives and Analgesics in the Treatment of Agitated Critically Ill Patients , 1997, Clinical pharmacokinetics.

[9]  S. Joel,et al.  The pharmacokinetics of morphine and morphine glucuronides in kidney failure , 1993, Clinical pharmacology and therapeutics.

[10]  S. Nasraway,et al.  How reliable is the Bispectral Index in critically ill patients? A prospective, comparative, single-blinded observer study* , 2002, Critical care medicine.

[11]  H. Schwilden,et al.  Closed-loop feedback control of propofol anaesthesia by quantitative EEG analysis in humans. , 1989, British journal of anaesthesia.

[12]  Dominic S. Lee,et al.  Modeling and control of the agitation-sedation cycle for critical care patients. , 2004, Medical engineering & physics.

[13]  G. Fraser,et al.  Assessing sedation during intensive care unit mechanical ventilation with the Bispectral Index and the Sedation-Agitation Scale. , 1999, Critical care medicine.

[14]  D. M. MacKay,et al.  Psychophysics of Perceived Intensity: A Theoretical Basis for Fechner's and Stevens' Laws , 1963, Science.

[15]  J. Bion,et al.  Sedation in intensive care: morphine and renal function , 2004, Intensive Care Medicine.

[16]  R. Moore,et al.  Systematic review of factors affecting the ratios of morphine and its major metabolites , 1998, Pain.

[17]  C. Perry,et al.  Propofol: a review of its use in intensive care sedation of adults. , 2003, CNS drugs.

[18]  J. Devlin,et al.  The Effect of ICU Sedation Guidelines and Pharmacist Interventions on Clinical Outcomes and Drug Cost , 1997, The Annals of pharmacotherapy.

[19]  S L Shafer,et al.  Response Surface Model for Anesthetic Drug Interactions , 2000, Anesthesiology.

[20]  R. Arbour.  Sedation and pain management in critically ill adults. , 2000, Critical care nurse.

[21]  G C Wake,et al.  Rethinking sedation and agitation management in critical illness. , 2003, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[22]  M. Morari,et al.  Multitasked closed-loop control in anesthesia , 2001, IEEE Engineering in Medicine and Biology Magazine.

[23]  P. Halpern,et al.  Midazolam infusion and the benzodiazepine antagonist flumazenil for sedation of intensive care patients. , 1988, Resuscitation.

[24]  Tep M Kang.  Propofol Infusion Syndrome in Critically Ill Patients , 2002, The Annals of pharmacotherapy.

[25]  J. Geoffrey Chase,et al.  Quantifying agitation in sedated ICU patients using digital imaging , 2004, Comput. Methods Programs Biomed..

[26]  J. Geoffrey Chase,et al.  Hinfinity control analysis of patient agitation management in the critically ill , 2005, Int. J. Intell. Syst. Technol. Appl..

[27]  C. Sessler,et al.  The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. , 2002, American journal of respiratory and critical care medicine.

[28]  Geoffrey M. Shaw,et al.  Impact of control on agitation–sedation dynamics , 2005 .

[29]  E. Kraegen,et al.  Blood Glucose Control by Intermittent Loop Closure in the Basal Mode: Computer Simulation Studies with a Diabetic Model , 1985, Diabetes Care.

[30]  A. Shafer.  Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. , 1998, Critical care medicine.

[31]  A. Guyton,et al.  Textbook of Medical Physiology , 1961 .

[32]  G. Wake,et al.  Modelling and control of the agitation-sedation cycle , 2003 .

[33]  R. Ollerton.  Application of optimal control theory to diabetes mellitus , 1989 .

[34]  C. A. Desoer,et al.  Nonlinear Systems Analysis , 1978 .

[35]  J. Kress,et al.  Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. , 2000, The New England journal of medicine.

[36]  C. Gross,et al.  Sedating critically ill patients: factors affecting nurses' delivery of sedative therapy. , 2001, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[37]  Meindert Danhof,et al.  Pharmacokinetic‐pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite α‐hydroxymidazolam in healthy volunteers , 1992, Clinical pharmacology and therapeutics.

[38]  G. Fraser,et al.  Monitoring sedation, agitation, analgesia, and delirium in critically ill adult patients. , 2001, Critical care clinics.

[39]  R. Waldhorn,et al.  Analgesia, sedation and paralysis in the intensive care unit. , 1995, American family physician.

[40]  J G Chase,et al.  Physiological modelling of agitation-sedation dynamics. , 2006, Medical engineering & physics.

[41]  A. Somogyi,et al.  The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. , 1996, Drug metabolism reviews.

[42]  H. Wallach,et al.  The perception of neutral colors. , 1963, Scientific American.

[43]  J. Chase,et al.  Physiologically-based minimal model of agitation-sedation dynamics , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[44]  C. Young,et al.  Benzodiazepines in the intensive care unit. , 2001, Critical care clinics.

[45]  Edward Abraham,et al.  Management of the agitated intensive care unit patient. , 2002, Critical care medicine.

[46]  Stephen P. Boyd,et al.  sdpsol: a parse/solver for semidefinite programs with matrix structure , 1999 .

[47]  L. Smith,et al.  The Pharmacokinetics of Midazolam in Chronic Renal Failure Patients , 1983, Anesthesiology.

[48]  Stephen P. Boyd,et al.  Method of centers for minimizing generalized eigenvalues , 1993, Linear Algebra and its Applications.

[49]  D. Greenblatt,et al.  In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution. , 1983, The Journal of pharmacology and experimental therapeutics.

[50]  E D Lehmann,et al.  Computer assisted diabetes care: a 6-year retrospective. , 1996, Computer methods and programs in biomedicine.

[51]  Michael Yudell,et al.  The genomic revolution : unveiling the unity of life , 2002 .

[52]  Geoffrey M Shaw,et al.  Derivative weighted active insulin control modelling and clinical trials for ICU patients. , 2004, Medical engineering & physics.

[53]  M Danhof,et al.  Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: midazolam and alpha-OH-midazolam. , 1999, The Journal of pharmacology and experimental therapeutics.

[54]  U. Hofmann,et al.  Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. , 2002, British journal of clinical pharmacology.

[55]  Theodore Speroff,et al.  Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. , 2004, JAMA.

[56]  D. Crippen.  Pharmacologic treatment of brain failure and delirium. , 1994, Critical care clinics.

[57]  Manfred Morari,et al.  A new paradigm for the closed-loop intraoperative administration of analgesics in humans , 2002, IEEE Transactions on Biomedical Engineering.

[58]  A. Dahan,et al.  Pharmacokinetic-Pharmacodynamic Modeling of Morphine-6-glucuronide-induced Analgesia in Healthy Volunteers: Absence of Sex Differences , 2004, Anesthesiology.

[59]  J. Scholz,et al.  Comparison of two bispectral index algorithms in monitoring sedation in postoperative intensive care patients* , 2005, Critical care medicine.

[60]  M. A. Hughes,et al.  Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. , 1992, Anesthesiology.

[61]  B. Silverman.  Density estimation for statistics and data analysis , 1986 .

[62]  H L Paz,et al.  Use of bispectral electroencephalogram monitoring to assess neurologic status in unsedated, critically ill patients , 2001, Critical care medicine.

[63]  R N Bergman,et al.  Assessment of insulin sensitivity in vivo. , 1985, Endocrine reviews.

[64]  Franck Agogue,et al.  Objective measurements of patient agitation in critical care using physiological signals and fuzzy systems , 2005 .

[65]  Jesse B. Hall,et al.  Sedation and analgesia in the intensive care unit. , 2002, American journal of respiratory and critical care medicine.

[66]  M Danhof,et al.  Pharmacokinetic‐pharmacodynamic modeling of midazolam effects on the human central nervous system , 1988, Clinical pharmacology and therapeutics.

[67]  G. Guyatt,et al.  Adaptation to the Intensive Care Environment (ATICE): Development and validation of a new sedation assessment instrument , 2003, Critical care medicine.

[68]  S. Cook.  PSYCHOLOGY: A STUDY OF A SCIENCE. VOLUME 3 , 1961 .

[69]  H E Hulshoff Pol,et al.  Effects of context on judgements of odor intensities in humans. , 1998, Chemical senses.

[70]  G. Fraser,et al.  Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. , 1999, Critical care medicine.

[71]  M. Ramsay,et al.  Controlled Sedation with Alphaxalone-Alphadolone , 1974, British medical journal.

[72]  L. Mather,et al.  Intrathecal and epidural administration of opioids. , 1984, Anesthesiology.

[73]  T. Vree,et al.  The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients. , 1991, Acta anaesthesiologica Belgica.

[74]  Jun S. Liu,et al.  Blind Deconvolution via Sequential Imputations , 1995 .

[75]  M. West.  Approximating posterior distributions by mixtures , 1993 .

[76]  A. Jaarsma,et al.  Biphasic positive airway pressure ventilation (PeV+) in children , 2001, Critical care.

[77]  R. MacLaren,et al.  A Prospective Evaluation of Empiric versus Protocol‐Based Sedation and Analgesia , 2000, Pharmacotherapy.